Markets:

Overview

News

Currencies

International

Treasuries

SI-BONE, Inc. - Common Stock (NQ:SIBN)

14.84 +0.08 (+0.54%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about SI-BONE, Inc. - Common Stock

< Previous 1 2 3 4 Next >

These Analysts Cut Their Forecasts On SI-BONE Following Q2 Results ↗

August 06, 2024

Via Benzinga

SIBN Stock Earnings: SI-BONE Beats EPS, Beats Revenue for Q2 2024 ↗

August 05, 2024

SIBN stock results show that SI-BONE beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

7 Leading MedTech Stocks for Next-Gen Health Solutions ↗

July 31, 2024

With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar.

Via InvestorPlace

A Closer Look at 6 Analyst Recommendations For SI-BONE ↗

May 07, 2024

Via Benzinga

SIBN Stock Earnings: SI-BONE Beats EPS, Beats Revenue for Q1 2024 ↗

May 06, 2024

SIBN stock results show that SI-BONE beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 06, 2024

Via Benzinga

Peeling Back The Layers: Exploring SI-BONE Through Analyst Insights ↗

March 28, 2024

Via Benzinga

Beyond The Numbers: 4 Analysts Discuss SI-BONE Stock ↗

February 27, 2024

Via Benzinga

Recap: SI-BONE Q4 Earnings ↗

February 26, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 27, 2024

Via Benzinga

Earnings Scheduled For February 26, 2024 ↗

February 26, 2024

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million.

Via Benzinga

SI-BONE's Earnings Outlook ↗

February 23, 2024

Via Benzinga

What Analysts Are Saying About SI-BONE Stock ↗

December 22, 2023

Via Benzinga

What 5 Analyst Ratings Have To Say About SI-BONE ↗

December 04, 2023

Via Benzinga

Cantor Fitzgerald Maintains Overweight Rating for SI-BONE: Here's What You Need To Know ↗

November 07, 2023

Via Benzinga

Where SI-BONE Stands With Analysts ↗

November 07, 2023

Via Benzinga

Earnings Scheduled For November 6, 2023 ↗

November 06, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.

Via Benzinga

Analyst Ratings for SI-BONE ↗

September 26, 2023

Via Benzinga

Analyst Ratings for SI-BONE ↗

August 08, 2023

Via Benzinga

Earnings Preview: SI-BONE ↗

August 04, 2023

Via Benzinga

The Latest Analyst Ratings for SI-BONE ↗

July 19, 2023

Via Benzinga

Why Shares of Si-Bone Jumped Tuesday ↗

May 02, 2023

The company reported first-quarter earnings and improved revenue guidance.

Via The Motley Fool

Canaccord Genuity Maintains Buy Rating for SI-BONE: Here's What You Need To Know ↗

May 02, 2023

Via Benzinga

The Latest Analyst Ratings for SI-BONE ↗

May 02, 2023

Via Benzinga

SI-BONE Earnings Preview ↗

April 28, 2023

Via Benzinga

SI-BONE Poised For A Surge: Analyst Highlights Upside Potential With New Product Launches ↗

July 12, 2023

Needham analyst David Saxon reiterated a Buy rating on SI-BONE, Inc (NASDAQ: SIBN),

Via Benzinga

Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review ↗

May 05, 2023

The major indexes retreated for most of the week on banking fears,

Via Investor's Business Daily

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 05, 2023

Via Benzinga

US Stocks Down; Chegg Crashes After Removing Guidance On ChatGPT Concerns ↗

May 02, 2023

U.S. stocks traded lower this morning even as the Federal Reserve’s two-day meeting began. Following the market opening Tuesday, the Dow traded down 0.47% to 33,891.31 while the NASDAQ fell 0.12% to...

Via Benzinga

Earnings Scheduled For May 1, 2023 ↗

May 01, 2023

Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

SI-BONE, Inc. - Common Stock (NQ:SIBN)

All News about SI-BONE, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today